ClinicalTrials.gg
Status unknownNCT01988207Updated Nov 20, 2013

Treating Laryngeal Hyperfunction With Flow Phonation

An interventional study of Vocal Hygiene Training and Flow Phonation Exercises in Muscle Tension Dysphonia, sponsored by University of Central Arkansas. Status unknown at 1 site in United States. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2013-11-20.

Sponsored by University of Central Arkansas · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2013), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 71 studies in Dysphonia with a site in United States — 20 open to participants now, 21 under way, 1 of them phase 3. Dysphonia · United States.

Planned enrollment
17th of 53
60 · median 32
Started
2013
with 2 others
No phase
31 of 71
12 open now
Registered
17th of 71
by date

Among the 71 studies in Dysphonia with a site in United States, this one is the 17th largest by planned enrollment of the 53 interventional ones, is one of 3 that started in 2013, is one of 31 with no phase, and was the 17th registered.

By phase

71 studies; the count open now beside each. This study's row is marked.

No phasethis study31 · 12 open
Observational18 · 4 open
Phase 1/25 · 0 open
Phase 45 · 1 open
Phase 14 · 2 open
Phase 24 · 0 open
Phase 2/32 · 0 open
Phase 32 · 1 open

By the year they started

First in 1992; this study’s year is marked. 3 started in 2013.

Size and results

Median enrollment 32 across the 53 interventional studies, 170 across the 18 observational. Of the 41 that completed or were terminated, 17 (41%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 71 studies in Dysphonia with a site in United States, or all of them as a file.
02

Study summary

The purposes of the proposed study are: a) to determine whether Flow Phonation can decrease Laryngeal Resistance (Rlaw) in patients with Muscle Tension Dysphonia (MTD); and b)establish the relationship between changes in measures of Rlaw and phonatory airflow to endoscopic, perceptual, acoustic, and handicap assessment ratings. MTD can have a debilitating effect on individuals who rely on their voices the most-teachers, preachers,salespeople, singers-costing them time, money, and even their jobs. It can lead to vocal fatigue, pain, and complete loss of voice. While treatments have emerged with some promising effects, no treatments have proven to have long-term benefits to all patients. Our preliminary data demonstrate Flow Phonation training resulted in significant decreases in Laryngeal Resistance to phonatory airflow with associated improvements in voice quality and voice handicap ratings. Sample size for our pilot study was small; no control group was utilized; and outcome measures were limited. In the proposed investigation, a larger sample will be obtained, a control group of participants receiving only Vocal Hygiene Training will be used for comparison during the first 3 weeks, and a wider range of outcome measures will be included over a longer period of time (1 year).

Read the detailed description

All participants will complete the Evaluation Protocol at baseline, after 3 weeks (PERIOD 1),after 6 weeks (PERIOD 2), and for follow-up at 3, 6, and 12 months post-treatment. During PERIOD 1 (first 3 weeks), participants in ARM 1 will receive Vocal Hygiene Training as well as Airflow Exercise Training and participants in ARM 2 (the Control Arm) will receive only Vocal Hygiene Training. Vocal hygiene training alone has been demonstrated to have minimal impact on voicing32-34. During Period 2 (second 3 weeks), participants in BOTH ARMS will receive Vocal Hygiene Training and Airflow Exercise Training (Fig 3). Thus, participants in Arm 2 will receive no Flow Phonation for initial controlled comparison then 3 weeks of Flow Phonation for dose response comparison to Arm 1 (non-control) participants.

Assessment Protocol

Each participant will receive the Complete Evaluation Protocol at Baseline, after 3 weeks(PERIOD 1), after an additional 3 weeks (PERIOD 2), as well as at 3, 6, and 12 months posttreatment. These will include:

a. Laryngostroboscopic Examination b) Perceptual Voice Analysis/CAPE-V48-49 c) Acoustic Analysis/Computerized Speech Lab(CSL, KayPENTAX Corp) d) Aerodynamic Analysis/The KayPENTAX Phonatory Aerodynamic System (PAS) Model 6600 (KayPENTAX Corp.

e) Patients' Perception of Voice Handicap/Voice Handicap Index

Treatment Protocol Flow Phonation Each treatment session will take place in the same clinical room as the assessment and utilize three exercises: gargling, cup bubble blowing, and stretch and flow. Each exercise uses a built in form of biofeedback (water or tissue) and the same basic progression of activities (with minor alterations): 1) airflow task without voicing to establish positive airflow; 2) adding voicing to the task; 3) moving up and down the pitch range during the voicing task; 4) moving to a speaking/voicing task; and 5) removing biofeedback. During each vocalization attempt, the clinician listens for a clear and effortless vocal quality and trains the participant to listen.

Vocal Hygiene Training Vocal hygiene training centers on three factors: 1) hydration, 2) exogenous inflammation control, and 3) abstinence from yelling and screaming. Information will be provided initially as a Powerpoint presentation, during which each participant will have a manual and will write down answers to specific questions. Based on responses to the questions, the study clinician, in concert with the participant, will develop a set of recommendations for vocal hygiene. Examples of potential vocal hygiene targets are provided in Table 2. Three to five recommendations will be targeted for each participant, based on clinical judgment, although these numbers will serve only as a guide.

Participants will be provided a daily log to utilize where they can mark each target daily and make comments on how the target was met or not met. Each treatment session where Vocal Hygiene Training is targeted, alone or in concert with Airflow Training, participants will first present their goals, then provide the daily log and discuss successes and failures since the prior session. The study clinician and participant will then discuss the benefits of the successes and problem solve ways to improve upon failures.

03

Conditions studied

  • Muscle Tension Dysphonia

Browse trials for

Keywords

  • Muscle Tension Dysphonia
  • Voice
  • Hyperfunction
04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Rlaw greater than 1 standard deviation above or below mean
  • Voice Handicap Index of greater than 18
  • CAPE-V severity of 20 or greater
  • willing to sign
  • women must not have experienced menopause or be pregnant

Exclusion criteria

Exclusion Criteria:

  • organic lesion of the vocal folds
  • history of neurologic disease
  • history of head and neck cancer
  • pulmonary disease
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    12 Exercise Sessions

    Patients will receive 12 treatment sessions with flow phonation exercises, as well as education on vocal hygiene.

    Behavioral: Vocal Hygiene Training · Behavioral: Flow Phonation Exercises

  • Active comparator
    6 Hygiene and 6 Exercise

    Patients will receive 6 sessions of vocal hygiene training for initial comparison to patients in Arm 1. They will then receive 6 sessions of vocal exercise training and vocal hygiene training combined.

    Behavioral: Vocal Hygiene Training · Behavioral: Flow Phonation Exercises

Interventions

  • BehavioralVocal Hygiene Training

    Patients will receive education on how to care for their voices on three factors: 1) hydration, 2) exogenous inflammation control, and 3) abstinence of yelling and screaming.

  • BehavioralFlow Phonation Exercises

    Three exercises are employed: gargling, cup bubble blowing, and stretch and flow (tissue blowing). Each is done without voicing, with voicing, and then with variations in pitch and verbalization.

06

What researchers measure

Primary outcomes

  1. Laryngeal Airway Resistance (Rlaw) Change Over Time

    Measured using the KayPENTAX Phonatory Aerodynamic System during a voice efficiency task (i.e., repeating "apapapapapapapa."

    Time frame: 3 weeks, 6 weeks, 12 weeks, 6 months, 12 months

Secondary outcomes

  1. Voice Handicap Index (VHI)

    The Voice Handicap Index is a 30 item questionnaire to assess the patient's perception of the impact of their voice on their quality of life and daily functioning.

    Time frame: 3 weeks, 6 weeks, 12 weeks, 6 months, 12 months

  2. Consensus Auditory Perceptual Evaluation - Voice

    The CAPE-V is a perceptual measure of voicing made by the clinician to rate the patient's vocal quality on a 100 mm line scale.

    Time frame: 3 weeks, 6 weeks, 12 weeks, 6 months, 12 months

  3. Noise-to-Harmonic Ratio

    The KayPENTAX Computerized Speech Lab will be used to record and analyze sustained phonation (AH) and provide a measure of noise to harmonic ratio.

    Time frame: 3 weeks, 6 weeks, 12 weeks, 3 months, 12 months

07

Study locations

1 site
  • University of Central Arkansas
    Conway, Arkansas 72035, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2013, a primary completion of Nov 2016 and a completion of Nov 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 16, 2013
First posted
Nov 20, 2013
Start
Dec 2013
Primary completionEst.
Nov 2016
CompletionEst.
Nov 2016
Last update
Nov 20, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 20, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01988207
Lead sponsor
University of Central Arkansas
Responsible party
Gary H. McCullough (Professor, Interim Dean of Graduate School, University of Central Arkansas) — Principal investigator
First posted
Nov 20, 2013
Start date
Dec 2013
Primary completion
Nov 2016 (estimated)
Completion
Nov 2016 (estimated)
Last update
Nov 20, 2013

Study contacts

Gary H McCullough, Ph.D.
Contact
gmccullough@uca.edu
501-450-3124
Gary H McCullough, Ph.D.
principal investigator · University of Central Arkansas

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion